![Qi Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 163 M $ al 30/09/2026
Dr. Qi Xu is a Chairman & Chief Executive Officer at Medtide, Inc. and a President & General Manager at Chinese Peptide Co. Dr. Xu was previously employed as a Director & Deputy General Manager by Guizhou Xinbang Pharmaceutical Co., Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEDTIDE, INC. CLASS H 42,01 % | 09/03/2026 | 59.567.875 ( 42,01 % ) | 163 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDTIDE INC. | Director Ejecutivo | 11/06/2020 |
Chinese Peptide Co.
 Chinese Peptide Co. BiotechnologyHealth Technology Manufactures and produces peptides | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| GUIZHOU XINBANG PHARMACEUTICAL CO., LTD. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Guizhou Xinbang Pharmaceutical Co., Ltd.
 Guizhou Xinbang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Chinese Peptide Co.
Chinese Peptide Co. BiotechnologyHealth Technology Manufactures and produces peptides | Health Technology |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
 Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Provides discovery, pre-clinical research, clinical development and production of drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
